EU AIDS WORKERS SHED BY SWEDISH PHARMA SECTOR
November 1st, 2012
BY KEITH NUTHALL
THE EUROPEAN Union (EU) Council of Ministers has approved paying Euro EUR4.3 million from the European Globalisation Adjustment Fund to help retrain 700 workers made redundant by AstraZeneca in Sweden. This followed an international rationalisation of its research units, with increased investment in China and Russia. The fund helps workers who lose jobs to lower-wage countries outside the EU.
ENDS
THE EUROPEAN Union (EU) Council of Ministers has approved paying Euro EUR4.3 million from the European Globalisation Adjustment Fund to help retrain 700 workers made redundant by AstraZeneca in Sweden. This followed an international rationalisation of its research units, with increased investment in China and Russia. The fund helps workers who lose jobs to lower-wage countries outside the EU.
ENDS
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.